Mylan Inc. has cleared another hurdle in its planned acquisition of an Indian pharmaceutical company. The Southpointe-based Mylan (Nasdaq: MYL) said it received approval from the Foreign Investment Promotion Board of India for its plan to acquire the Agila injectables business from Strides Arcolab Ltd. It plans to finish the $1.6 billion purchase sometime in the fourth quarter. Help employers find you! Check out all the jobs and post your resume.
Mylan Inc. has cleared another hurdle in its planned acquisition of an Indian pharmaceutical company. The Southpointe-based Mylan (Nasdaq: MYL) said it received approval from the Foreign Investment Promotion Board of India for its plan to acquire the Agila injectables business from Strides Arcolab Ltd. It plans to finish the $1.6 billion purchase sometime in the fourth quarter. Help employers find you! Check out all the jobs and post your resume.
